But a tool sold as a cure to a population financially stretched to afford it is not healthcare innovation
Firms with 3-49 employees responding to this follow-up survey have reported a higher offer rate than the full EHBS survey during the 2014, 2016, 2017, 2018, and 2019 surveys
Potential limitations of the FLOW study One limitation of the trial included the fact that roughly two-thirds of participants were white and approximately two-thirds were male
For many of them, that wait is over as we can now offer the powerful efficacy of Wegovy in a once-daily pill that demonstrated about 17% weight loss, if all patients stayed on treatment. The UKs medicines regulator is reviewing the companys application for its Wegovy pill and is expected to make a decision on whether to approve it before the end of the year.
Gently grasp the skin at the back of the arm between your thumb and first 2 fingers
ResX is sending a package of JDC1s out this weekend with lighting designer Kait Hall to make their debut